Pub Date : 2021-03-01DOI: 10.5772/INTECHOPEN.95919
S. Heffernan, G. Conway
Chronic pain is a considerable health concern worldwide, effecting almost 30% of all European adults. Osteoarthritis (OA), a progressive pro-inflammatory condition, is one of the leading causes of chronic pain (effecting 13% of all those over 50 years, globally) and is the most common cause of joint pain. The prevalence of non-steroidal anti-inflammatory drug (NSAIDs) and analgesic use has been well studied and is abundant throughout the western world, with women being the greatest users and ibuprofen generally being the most reported NSAID. In the US, 65% of all OA patients are prescribed NSAIDs for pain management and form part of the current recommended strategy for OA clinical management. While some NSAIDs and analgesics are effective at improving pain and physical function, they come with significant and harmful side effects such as gastrointestinal complications, renal disturbances and severe cardiovascular events. Given these side-effects, any reduction in NSAID and analgesia use (and the resulting potentially harmful side effects) is of particular importance to OA public health. As such, a number of non-pharmaceutical alternatives (bioactive nutraceuticals) have been developed that may reduce NSAID and analgesia use while maintaining pain reduction and improvements in physical function. This chapter will discuss select nutraceuticals that are not currently in mainstream use but may have the potential to aid in the treatment of OA.
{"title":"Nutraceutical Alternatives to Pharmaceutical Analgesics in Osteoarthritis","authors":"S. Heffernan, G. Conway","doi":"10.5772/INTECHOPEN.95919","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.95919","url":null,"abstract":"Chronic pain is a considerable health concern worldwide, effecting almost 30% of all European adults. Osteoarthritis (OA), a progressive pro-inflammatory condition, is one of the leading causes of chronic pain (effecting 13% of all those over 50 years, globally) and is the most common cause of joint pain. The prevalence of non-steroidal anti-inflammatory drug (NSAIDs) and analgesic use has been well studied and is abundant throughout the western world, with women being the greatest users and ibuprofen generally being the most reported NSAID. In the US, 65% of all OA patients are prescribed NSAIDs for pain management and form part of the current recommended strategy for OA clinical management. While some NSAIDs and analgesics are effective at improving pain and physical function, they come with significant and harmful side effects such as gastrointestinal complications, renal disturbances and severe cardiovascular events. Given these side-effects, any reduction in NSAID and analgesia use (and the resulting potentially harmful side effects) is of particular importance to OA public health. As such, a number of non-pharmaceutical alternatives (bioactive nutraceuticals) have been developed that may reduce NSAID and analgesia use while maintaining pain reduction and improvements in physical function. This chapter will discuss select nutraceuticals that are not currently in mainstream use but may have the potential to aid in the treatment of OA.","PeriodicalId":106733,"journal":{"name":"Pain Management - Practices, Novel Therapies and Bioactives","volume":"74 6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131373847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-04DOI: 10.5772/INTECHOPEN.95276
E. Oktem, Seyda Cankaya
Empathy is essential for being human for understanding and sharing other people’s affective and mood, including pain. Pain empathy is a mental ability that allows one person to understand another person’s pain and how to respond to that person effectively. The same neural structures as pain and empathy have recently been found to be involved in functional magnetic resonance imaging (fMRI) studies. When someone witnesses other’s pain, besides the visual cortex, various parts of the nervous system activate, including the neural network of empathy. Empathy includes not only pain but also other emotions, such as anger, sadness, fear, distress. These findings raised beg the question of whether empathy for pain is unique in its neural correlates. It is essential to know for revealing empathy is a specific context or in a state of chronic pain, depression or anxiety disorders. Because of this, pain empathy has been the central focus of empathy research in social neuroscience and other related fields, highlighting the importance of empathy for pain in daily life. Considering how pain plays a crucial role in the quality of life, determining its network and neurocognitive correlations in the empathy processing may provide a novel therapeutic approach for pain management. This area, which is still under investigation, can provide new information about pain. Under the recent studies and hypothesis, we have aimed to clarify the term of pain empathy, its components, and its neural correlates.
{"title":"Empathy for Pain","authors":"E. Oktem, Seyda Cankaya","doi":"10.5772/INTECHOPEN.95276","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.95276","url":null,"abstract":"Empathy is essential for being human for understanding and sharing other people’s affective and mood, including pain. Pain empathy is a mental ability that allows one person to understand another person’s pain and how to respond to that person effectively. The same neural structures as pain and empathy have recently been found to be involved in functional magnetic resonance imaging (fMRI) studies. When someone witnesses other’s pain, besides the visual cortex, various parts of the nervous system activate, including the neural network of empathy. Empathy includes not only pain but also other emotions, such as anger, sadness, fear, distress. These findings raised beg the question of whether empathy for pain is unique in its neural correlates. It is essential to know for revealing empathy is a specific context or in a state of chronic pain, depression or anxiety disorders. Because of this, pain empathy has been the central focus of empathy research in social neuroscience and other related fields, highlighting the importance of empathy for pain in daily life. Considering how pain plays a crucial role in the quality of life, determining its network and neurocognitive correlations in the empathy processing may provide a novel therapeutic approach for pain management. This area, which is still under investigation, can provide new information about pain. Under the recent studies and hypothesis, we have aimed to clarify the term of pain empathy, its components, and its neural correlates.","PeriodicalId":106733,"journal":{"name":"Pain Management - Practices, Novel Therapies and Bioactives","volume":"111 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132557602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-11-30DOI: 10.5772/intechopen.94146
M. Różycki, R. Tobias
Pain is the subjective sensation closely related to disease and treatment. Very often its diagnosis is more an expression of the diagnostician’s experience than a description of the patient’s actual condition. In particular, orthopedic and neurological patients who develop Complex Regional Pain Syndrome are misdiagnosed because the intensity of their sensations is disbelieved. Based on case studies, it seems appropriate to introduce an additional category of patient experience that will enable prompt recognition and appropriate treatment. The misdiagnoses under evaluation also exhibit frequent improper practitioner responses to patients’ experience, ranging from open expressions of disbelief, through indifference, to helplessness and pessimism. This article presents case studies in which patients’ expressions of suffering were not used to modify the treatment. Rather, medical professionals accepted the pain as normal under the circumstances and resulting from tissue damage. However, in these cases, the pain was a symptom of a new disease entity, in development since the original diagnosis. With improved patient communication and treatment procedures, such oversights can be avoided and new disease entities will be more readily diagnosable.
{"title":"Suffering as a Diagnostic Indicator","authors":"M. Różycki, R. Tobias","doi":"10.5772/intechopen.94146","DOIUrl":"https://doi.org/10.5772/intechopen.94146","url":null,"abstract":"Pain is the subjective sensation closely related to disease and treatment. Very often its diagnosis is more an expression of the diagnostician’s experience than a description of the patient’s actual condition. In particular, orthopedic and neurological patients who develop Complex Regional Pain Syndrome are misdiagnosed because the intensity of their sensations is disbelieved. Based on case studies, it seems appropriate to introduce an additional category of patient experience that will enable prompt recognition and appropriate treatment. The misdiagnoses under evaluation also exhibit frequent improper practitioner responses to patients’ experience, ranging from open expressions of disbelief, through indifference, to helplessness and pessimism. This article presents case studies in which patients’ expressions of suffering were not used to modify the treatment. Rather, medical professionals accepted the pain as normal under the circumstances and resulting from tissue damage. However, in these cases, the pain was a symptom of a new disease entity, in development since the original diagnosis. With improved patient communication and treatment procedures, such oversights can be avoided and new disease entities will be more readily diagnosable.","PeriodicalId":106733,"journal":{"name":"Pain Management - Practices, Novel Therapies and Bioactives","volume":"67 1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123248592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-09-25DOI: 10.5772/INTECHOPEN.93851
Asma Al-Shidhani, A. Al-Mahrezi
Cupping therapy is an ancient method which has been used for centuries for various painful conditions. It is performed by applying cups to selected skin points most commonly in the back aiming to create areas of sub-atmospheric pressure. It has been classified as either dry or wet type of therapy. Its mechanism of action is not well understood but several proposed mechanisms are described in the literature. It is relatively safe with a few reported side effects which include scar formation and skin infection. In this paper, a review of the literature will be presented to determine its potential benefits in pain management particularly in musculo-skeletal conditions such as low back and neck pain.
{"title":"The Role of Cupping Therapy in Pain Management: A Literature Review","authors":"Asma Al-Shidhani, A. Al-Mahrezi","doi":"10.5772/INTECHOPEN.93851","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.93851","url":null,"abstract":"Cupping therapy is an ancient method which has been used for centuries for various painful conditions. It is performed by applying cups to selected skin points most commonly in the back aiming to create areas of sub-atmospheric pressure. It has been classified as either dry or wet type of therapy. Its mechanism of action is not well understood but several proposed mechanisms are described in the literature. It is relatively safe with a few reported side effects which include scar formation and skin infection. In this paper, a review of the literature will be presented to determine its potential benefits in pain management particularly in musculo-skeletal conditions such as low back and neck pain.","PeriodicalId":106733,"journal":{"name":"Pain Management - Practices, Novel Therapies and Bioactives","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130738243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-09-07DOI: 10.5772/intechopen.93588
Ensa Johnson
Communication vulnerable children need an alternative way to express their pain to receive appropriate pain management. In this chapter, the concept of communication vulnerability will be explained by using the social-communication model of pain as a theoretical framework. The concept of pain is difficult to describe due to its subjective nature and individuals’ different experiences to pain. Clinicians and researchers find it challenging to understand the dynamic interplay between the biological, psychological and social determinants of pain. Understanding any episode of acute or chronic pain therefore necessitates considering the holistic pain picture to analyse the essentials at biological, psychological and social levels. The chapter concludes with suggestions to use augmentative and alternative strategies to support communication vulnerable children to communicate their pain.
{"title":"Supporting Communication Vulnerable Children to Communicate Their Pain","authors":"Ensa Johnson","doi":"10.5772/intechopen.93588","DOIUrl":"https://doi.org/10.5772/intechopen.93588","url":null,"abstract":"Communication vulnerable children need an alternative way to express their pain to receive appropriate pain management. In this chapter, the concept of communication vulnerability will be explained by using the social-communication model of pain as a theoretical framework. The concept of pain is difficult to describe due to its subjective nature and individuals’ different experiences to pain. Clinicians and researchers find it challenging to understand the dynamic interplay between the biological, psychological and social determinants of pain. Understanding any episode of acute or chronic pain therefore necessitates considering the holistic pain picture to analyse the essentials at biological, psychological and social levels. The chapter concludes with suggestions to use augmentative and alternative strategies to support communication vulnerable children to communicate their pain.","PeriodicalId":106733,"journal":{"name":"Pain Management - Practices, Novel Therapies and Bioactives","volume":"96 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128066831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-09-03DOI: 10.5772/intechopen.93620
A. Paladini, G. Varrassi
The knowledge of the pathophysiology of pain has gradually evolved in recent years, allowing the development of new management strategies, more specifically addressing single pain types and patient profiles. Despite these advancements, pain management still remains an open issue, given the limitations of single agent therapies, the potential abuse/misuse of opioids and the risk of adverse events. The advent of multimodal analgesic strategies paves the way for major improvements in pain management, combining increased efficacy with better tolerability and an opioid-sparing effect. The association of analgesics with different mechanisms of action represents a successful strategy for a wide range of pain conditions, minimizing side effects and taking advantage of the additive or synergistic actions of individual agents. Last but not least, the increasing availability of oral fixed-dose combinations of analgesics will offer further advantages over extemporaneous combinations, by increasing ease of administration and patient adherence to treatment.
{"title":"Multimodal Pharmacological Analgesia in Pain Management","authors":"A. Paladini, G. Varrassi","doi":"10.5772/intechopen.93620","DOIUrl":"https://doi.org/10.5772/intechopen.93620","url":null,"abstract":"The knowledge of the pathophysiology of pain has gradually evolved in recent years, allowing the development of new management strategies, more specifically addressing single pain types and patient profiles. Despite these advancements, pain management still remains an open issue, given the limitations of single agent therapies, the potential abuse/misuse of opioids and the risk of adverse events. The advent of multimodal analgesic strategies paves the way for major improvements in pain management, combining increased efficacy with better tolerability and an opioid-sparing effect. The association of analgesics with different mechanisms of action represents a successful strategy for a wide range of pain conditions, minimizing side effects and taking advantage of the additive or synergistic actions of individual agents. Last but not least, the increasing availability of oral fixed-dose combinations of analgesics will offer further advantages over extemporaneous combinations, by increasing ease of administration and patient adherence to treatment.","PeriodicalId":106733,"journal":{"name":"Pain Management - Practices, Novel Therapies and Bioactives","volume":"172 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117338332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-07-22DOI: 10.5772/intechopen.93265
I. Banjari, Jelena Balkić, V. Waisundara
Chronic pain is a noteworthy health issue with immense impact on global healthcare systems. Although this issue has not come into the limelight as other noncommunicable diseases, it should be highlighted that modern medicine still has no efficient treatment to curb chronic pain. In this aspect, essential oils have been used for the prevention of several disease conditions including pain management. These odorous products, obtained from botanically defined raw material, have a variable and complex composition. Their composition largely depends on the extraction technique used, from simple hydro-distillation, to supercritical or microwave-assisted extraction. Monoterpenoids are some of the most biologically active and highly researched compounds when it comes to antinociceptive effects. They are volatile oils, primarily composed of two isoprene units with highly distinctive aromas and flavors. More than 90% of the essential oils of medicinal plants consist of monoterpenoids like limonene, myrcene, α-terpineol, linalool, pinene, p-cymene, and nerol. Besides strong anti-inflammatory effect, all essential oils with high D-limonene content pose a significant free radical scavenging effect, predominantly disabling the production of reactive oxygen species. Further studies in humans are encouraged to determine the real long-term potential in treating chronic pain.
{"title":"Analgesic Potential of Monoterpenes from Citrus Essential Oils","authors":"I. Banjari, Jelena Balkić, V. Waisundara","doi":"10.5772/intechopen.93265","DOIUrl":"https://doi.org/10.5772/intechopen.93265","url":null,"abstract":"Chronic pain is a noteworthy health issue with immense impact on global healthcare systems. Although this issue has not come into the limelight as other noncommunicable diseases, it should be highlighted that modern medicine still has no efficient treatment to curb chronic pain. In this aspect, essential oils have been used for the prevention of several disease conditions including pain management. These odorous products, obtained from botanically defined raw material, have a variable and complex composition. Their composition largely depends on the extraction technique used, from simple hydro-distillation, to supercritical or microwave-assisted extraction. Monoterpenoids are some of the most biologically active and highly researched compounds when it comes to antinociceptive effects. They are volatile oils, primarily composed of two isoprene units with highly distinctive aromas and flavors. More than 90% of the essential oils of medicinal plants consist of monoterpenoids like limonene, myrcene, α-terpineol, linalool, pinene, p-cymene, and nerol. Besides strong anti-inflammatory effect, all essential oils with high D-limonene content pose a significant free radical scavenging effect, predominantly disabling the production of reactive oxygen species. Further studies in humans are encouraged to determine the real long-term potential in treating chronic pain.","PeriodicalId":106733,"journal":{"name":"Pain Management - Practices, Novel Therapies and Bioactives","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126112926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：